|
Neuroprotectors
Citations 111-120 of 537 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Meta-Analysis of the Efficacy of Granulocyte-Colony Stimulating Factor in Animal Models of Focal Cerebral Ischemia
- Jens Minnerup, Jan Heidrich, Jürgen Wellmann, Andreas Rogalewski, Armin Schneider, and Wolf-Rüdiger Schäbitz
Stroke published April 10, 2008, doi:10.1161/STROKEAHA.107.506816
[Abstract]
- Articles
DP-b99, a Membrane-Activated Metal Ion Chelator, as Neuroprotective Therapy in Ischemic Stroke
- Hans-Christoph Diener, Dietmar Schneider, Yair Lampl, Natan M. Bornstein, Alexander Kozak, Gilad Rosenberg on Behalf of the Study Group
Stroke published April 10, 2008, doi:10.1161/STROKEAHA.107.506378
[Abstract]
- Articles
Effects of Neuroglobin Overexpression on Acute Brain Injury and Long-Term Outcomes After Focal Cerebral Ischemia
- Xiaoying Wang, Jianxiang Liu, Haihao Zhu, Emiri Tejima, Kiyoshi Tsuji, Yoshihiro Murata, Dmitriy N. Atochin, Paul L. Huang, Chenggang Zhang, and Eng H. Lo
Stroke published April 10, 2008, doi:10.1161/STROKEAHA.107.506022
[Abstract]
- Original Contributions
Insulin Growth Factor-1 Gene Transfer Enhances Neurovascular Remodeling and Improves Long-Term Stroke Outcome in Mice
- Wei Zhu, Yongfeng Fan, Tim Frenzel, Mehdi Gasmi, Raymond T. Bartus, William L. Young, Guo-Yuan Yang, and Yongmei Chen
Stroke 2008;39:1254-1261; published online before print as doi:10.1161/STROKEAHA.107.500801
[Abstract]
[Full text]
- Original Contributions
Simvastatin Reduces the Association of NMDA Receptors to Lipid Rafts: A Cholesterol-Mediated Effect in Neuroprotection
- Jovita Ponce, Natalia Pérez de la Ossa, Olivia Hurtado, Mónica Millan, Juan F. Arenillas, Antonio Dávalos, and Teresa Gasull
Stroke 2008;39:1269-1275; published online before print as doi:10.1161/STROKEAHA.107.498923
[Abstract]
[Full text]
- Original Contributions
Xenon and Hypothermia Combine Additively, Offering Long-Term Functional and Histopathologic Neuroprotection After Neonatal Hypoxia/Ischemia
- Catherine Hobbs, Marianne Thoresen, Alexander Tucker, Kristian Aquilina, Ela Chakkarapani, and John Dingley
Stroke 2008;39:1307-1313; published online before print as doi:10.1161/STROKEAHA.107.499822
[Abstract]
[Full text]
- Emerging Therapies
A Critique of SAINT II: Wishful Thinking, Dashed Hopes, and the Future of Neuroprotection for Acute Stroke
- Sean I. Savitz and Wolf-Rüdiger Schäbitz
Stroke 2008;39:1389-1391; published online before print as doi:10.1161/STROKEAHA.107.504415
[Full text]
- Articles
Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia
- Wenri Zhang, Takashi Otsuka, Nobuo Sugo, Ardi Ardeshiri, Yazan K. Alhadid, Jeffrey J. Iliff, Andrea E. DeBarber, Dennis R. Koop, and Nabil J. Alkayed
Stroke published March 27, 2008, doi:10.1161/STROKEAHA.107.508325
[Abstract]
- Articles
Is It Time to Definitely Abandon Neuroprotection in Acute Ischemic Stroke?
- Maria Luisa Sacchetti
Stroke published March 27, 2008, doi:10.1161/STROKEAHA.107.505024
[Abstract]
- Articles
NXY-059 for the Treatment of Acute Stroke. Pooled Analysis of the SAINT I and II Trials
- Hans-Christoph Diener, Kennedy R. Lees, Patrick Lyden, Jim Grotta, Antoni Davalos, Stephen M. Davis, Ashfaq Shuaib, Tim Ashwood, Warren Wasiewski, Vivian Alderfer, Hans-Goran Hårdemark, Larry Rodichok for the SAINT I and II Investigators
Stroke published March 27, 2008, doi:10.1161/STROKEAHA.107.503334
[Abstract]
|
|
